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SUMMARY
Objectives To determine gait and inflammatory response in a rat hip pain model produced by 
intra-articular injection of nerve growth factor （NGF）.
Methods Using 36 8-week-old male Sprague Dawley rats, 30 µl of saline （sham-operated group; 
n＝12）, 30 µL of 50 µg/mL of NGF （NGF50 group; n＝12）, and 30 µL of 100 µg/mL of NGF （NGF100 
group; n＝12） were injected into the left hip. The gait of 6 rats in each group was analyzed using a 
CatWalk system. The levels of inflammatory cytokines were determined with the synovium and femoral 
head.
Results The maximum contact area was significantly decreased in the NGF100 group compared 
with in the sham-operated group on day 14. Swing speed significantly decreased in the NGF50 and 
NGF100 groups compared with in the sham-operated group on day 14. Duty cycle significantly 
decreased in the NGF50 and NGF100 groups compared with the sham-operated group on day 14. 
TNF-α, IL-1β, and IL-6 were significantly elevated in NGF50 and NGF100 groups compared with the 
sham-operated group.
Conclusions NGF into the rat hip joint induces an increase of inflammatory cytokines in the 
synovium and elicits pain escape behavior.
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Ⅰ．Introduction
 The pathogenesis of hip pain is unclear and the 
roles of sensory innervation and the nature of pain 
transmitting substances in the hip joint have not been 
fully elucidated. Previously, we reported that dorsal 
root ganglion （DRG） neurons innervating the hip are 
distributed on multiple levels （L1-L4）［1］, and that 
there is a difference in the level of innervation between 
the hip and inguinal skin［2］. Moreover, DRG neurons 
that innervate the hip and inguinal skin may overlap
［3］. Animal models of hip pain are essential to clarify 
the pathogenesis of hip pain. However, such models 
of hip pain have not been widely reported. We have 
established two novel rat models of hip pain produced 
by intra-articular administration into the hip joint with 
mono-iodoacetate［4］or nerve growth factor （NGF）［5］. 
NGF is a neurotrophin that is well known to regulate 
neuronal development, survival, and maintenance［6］. 
NGF also seems to influence chronic pain states, notably 
those associated with inflammation, and may be a target 
for analgesia in patients with osteoarthritis （OA）［7］. 
Intra-articular injection of NGF into rat hips produced 
microinflammation without osteoarthritic change［5］. 
Intra-articular injection of NGF into rat knees evoked 
pain-related behavior［8］. NGF is associated with 
angiogenesis at the osteochondral junction in patients 
with arthritis［9］. We hypothesized that direct application 
of NGF into the hip joint evokes an inflammatory 
condition without degeneration of the articular cartilage 
and that NGF can be used to model inflammatory hip 
pain in rats. However, the direct effects of intra-articular 
injection of NGF into normal rat hips on pain mediators 
and pain-related behavior are not yet known.
 A CatWalk gait analysis system is able to perform 
detailed gait analysis noninvasively and repeatedly［10］. 
This system has been described in detail elsewhere
［11-14］. The time course of pain-related mediator 
appearance can be analyzed using enzyme-linked 
immunosorbent assay （ELISA） to determine the levels 
of inflammatory cytokines, focusing on inflammatory 
and neuropathic pain-related states using local tissues 
and peripheral sensory innervation including DRGs.
 The purpose of this study was to evaluate pain-
related behavior using the CatWalk gait analysis system 
and the synovial levels of inflammatory cytokines in 
a rat model of hip pain produced by intra-articular 
injection of NGF into the hip joint.
Ⅱ．Materials and Methods
 We used 36 8-week-old male Sprague Dawley 
rats weighing from 250 to 300 g. The protocols for 
the animal procedures in our experiments followed 
the 1996 revision of the National Institutes of Health 
guidelines for the Care and Use of Laboratory Animals 
and received prior approval from the ethics committee 
of our institution. The rats were anesthetized by an 
intraperitoneal injection of sodium pentobarbital （40 
mg/kg） and were treated aseptically throughout the 
experiments. Using a 26-gauge needle, the following 
solutions were injected into the left hip of rats assigned 
to various groups according to their treatment: 30 µL 
of saline in rats in a sham-operated group （n＝12）, 30 
µL of 50 µg/mL of NGF （recombinant human b-NGF, 
256-GF-100/CF; R&D Systems, Minneapolis, MN） in 
rats in a NGF50 group （n＝12）, and 30 µL of 100µg/
mL of NGF in rats in a NGF100 group （n＝12）. The 
intra-articular injections were limited to the joint cavity. 
The rats were allowed unrestricted cage activity after the 
injection.
Experiment 1: gait parameters
 The CatWalk system （Noldus Information 
Technology, Wageningen, The Netherlands） was used 
to evaluate gait characteristics in the present study. 
Rats were placed on a glass plate located in a darkened 
room and allowed to walk freely. A light beam from a 
fluorescent lamp was shone through the glass plate. The 
light was normally reflected internally, except in areas 
where the rat’s paw touched the glass plate, where the 
light was refracted on the opposite side. This produced a 
sharp bright image of the paw print as seen from under 
the plate where the rat walked, and the entire run was 
recorded using a video camera. The data were acquired, 
compressed, and analyzed using CatWalk system 
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software. In the present study, the gait patterns of 6 
rats in each group were recorded 3 times and analyzed 
automatically using the CatWalk system.
 We compared 18 parameters of hind paw gait 
between the 3 groups. The ratios of the affected side to 
the unaffected side were taken as adjusted data for each 
parameter. The rat gait patterns were recorded on day 
0 （before injection, n＝6） and again on days 7 and 14 
after the injection （before they were humanely killed, 
n＝6, respectively）.
Experiment 2: inflammatory response
 For each group, 6 rats were killed after Experiment 
1 on day 7, while the remaining 6 were killed on day 
14. Rats were deeply anesthetized using 40mg/kg 
sodium pentobarbital and their left hips were exposed; 
the synovium and femoral head cartilage were resected 
for cytokine ELISAs. Tumor necrosis factor （TNF）-α, 
interleukin （IL）-1β, and IL-6 production in the 
synovium and the femoral head cartilage were quantified 
using ELISAs in accordance with the manufacturer’s 
protocols （R&D Systems, Minneapolis, MN）. Tissue 
protein was assayed using a kit in accordance with the 
manufacturer’s protocol （Bio-Rad, Hercules, CA）, and 
cytokine levels were normalized to tissue protein levels.
Statistical Analysis
 All values were calculated and statistically 
compared using unpaired t test followed by Bonferroni’s 
correction. A P＜0.05 was considered to be significant.
Ⅲ．Results
Experiment 1: gait parameters
 Of 18 parameters for hind paws, maximum contact 
area （the maximum area of paw contact with the glass 
plate）, swing speed （the speed of the paw during gait）, 
and duty cycle （duration of paw contact divided by time 
between consecutive paw contacts: contact/（contact＋
swing）×100％） were determined to be significantly 
different between the 3 groups. Maximum contact 
area tended to decrease from day 0 to day 7 after NGF 
injection in rats in all 3 groups and then significantly 
decreased in rats in the NGF100 group compared with 
rats in the sham-operated group on day 14 （81.3％ 
versus 95.8％, P＝0.0002, Figure 1）. Swing speed 
tended to decrease from day 0 to day 7 after NGF 
injection in rats in all 3 groups and then significantly 
decreased in rats in both the NGF50 and NGF100 
groups compared with rats in the sham-operated group 
on day 14 （80.3％ versus 82.2％ versus 96.2％, P＝
0.0001 and P＝0.0005, respectively, Figure 2）. Duty 
cycle tended to decrease from day 0 to day 7 after NGF 
injection in rats in all 3 groups and then significantly 
Fig. 1　Maximum contact area.
　The values are adjusted by the ratio of the affected 
to unaffected side （％）. Maximum contact area was 
significantly decreased in rats in the NGF100 group 
compared with rats in the sham-operated group on day 14. 
Bars represent standard deviation. *P＜0.05.
Fig. 2　Swing speed.
　The values are adjusted by the ratio of the affected 
to unaffected side （％）. Swing speed was significantly 
decreased in rats in both the NGF50 and NGF100 groups 
compared with that in rats in the sham-operated group on 
day 14. Bars represent standard deviation. *P＜0.05.
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decreased in rats in both the NGF50 and NGF100 
groups compared with rats in the sham-operated group 
on day 14 （82.4％ versus 83.0％ versus 96.7％, P＝
0.0007 and P＝0.0005, respectively, Figure 3）.
Experiment 2: inflammatory response
 Synovial membrane levels of TNF-α （pg/mg 
protein） were significantly elevated on day 14 after the 
injection compared with day 7 in rats in both the NGF50 
and NGF100 groups （1.46 versus 1.08, P＝0.0019 and 
1.55 versus 1.12, P＝0.0004, respectively, Figure 4）. 
The TNF-α levels were also significantly higher in rats 
in the NGF100 group than in rats in the sham-operated 
group on day 14 （1.55 versus 1.22, P＝0.0025）. 
Synovial membrane levels of IL-1β （pg/mg protein） 
were significantly higher in rats in both the NGF100 
and NGF50 groups than in rats in the sham-operated 
group on day 7 （11.2 versus 9.8 versus 7.8, P＝0.0001 
and P＝0.0006, respectively, Figure 5）. However, the 
difference was no longer significant on day 14. Synovial 
membrane levels of IL-6 （pg/mg protein） were 
significantly higher in rats in the NGF100 group than 
in rats in both the sham-operated and NGF50 groups 
Fig. 3　Duty cycle. 
　The values are adjusted by the ratio of the affected 
to unaffected side （％）. Duty cycle was significantly 
decreased in rats in both the NGF50 and NGF100 groups 
compared with that in rats in the sham-operated group on 
day 14. Bars represent standard deviation. *P＜0.05.
Fig. 4　Synovial levels of TNF-α.
　The synovial levels of TNF-α were significantly elevated 
on day 14 after the intra-articular injection of NGF compared 
with levels on day 7 in rats in both the NGF50 and NGF100 
groups. The synovial levels of TNF-α were significantly 
higher in rats in NGF100 group than in rats in the sham-
operated group on day 14. Bars represent standard deviation. 
*P＜0.05.
Fig. 5　Synovial levels of IL-1β.
　The synovial levels of IL-1β were significantly higher 
in rats in the NGF100 group than in rats in the sham-
operated group on day 7. Bars represent standard deviation. 
*P＜0.05.
Fig. 6　Synovial levels of IL-6.
　The synovial levels of IL-6 were significantly higher in 
rats in the NGF100 group than in rats in both the sham-
operated and NGF50 groups on day 14. Bars represent 
standard deviation. *P＜0.05, **P＜0.01.
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contact intensity （the mean intensity of all the pixels 
contributing to the maximum paw print area） were 
significantly less than in the control group.
 The current report is also the first describing a 
rat model of hip pain associated with an increase 
in synovial levels of proinflammatory cytokines, 
including TNF-α, IL-1β, and IL-6 levels as assessed 
by ELISA. Intra-articular NGF administration into the 
rat hip was associated with an increase in the synovial 
level of inflammatory cytokines. Sensory innervation 
and inflammatory cytokines in hypertrophic synovial 
membranes are associated with nociception in OA of the 
hip in humans［15］. IL-6 and TNF-α levels are elevated 
in synovial joint fluid in patients with hip disease, 
reflecting tissue destruction in OA［16］. In the present 
study, synovial levels of TNF-α were significantly 
elevated on day 14 after the injection compared with 
the levels on day 7 in rats in both the NGF 50 and 100 
groups. Synovial levels of IL-1β were significantly 
higher in rats in both the NGF 50 and 100 groups than in 
rats in the sham-operated group on day 7, although the 
difference was no longer significant on day 14. IL-1β 
is therefore likely to play a role in early inflammation. 
Synovial levels of IL-6 were significantly higher in rats 
in the NGF 100 group than in rats in the sham-operated 
and NGF 50 groups on day 14, although the levels were 
not significantly different on day 7. Thus, IL-6 is likely 
to play a role in delayed inflammation. Our findings 
suggest that NGF is crucially involved in the behavioral 
expression and neural transmission of pain from the hip 
joint.
 There are several limitations to this study. First, 
dose dependency was not determined because only 2 
doses of NGF were examined. Further doses of NGF 
should be studied to determine dose dependency. 
Second, gait parameters and inflammatory response 
were evaluated at only 2 time points. Pain-related 
behavior was significantly different between rats in 
the various treatment groups on day 14. In a previous 
study, pathology of the hip and immunohistochemistry 
of the DRG showed mild synovitis and expression of 
calcitonin gene-related peptide-immunoreactive neurons 
in sensory nerves on day 7 that persisted on day 14［5］. 
on day 14 （39.4 versus 33.1 versus 30.8, P＝0.0007 
and P＝0.0001, respectively, Figure 6）, although no 
significant difference was found on day 7.
 There were no significant differences in cytokine 
levels in the femoral head cartilage at any time after the 
various treatments. The TNF-α levels in the femoral 
head cartilage were 1.22, 1.21, and 1.23 pg/mg protein 
in rats in the sham-operated, NGF50, and NGF100 
groups on day 7, and 1.25, 1.27, and 1.29 pg/mg protein 
on day 14, respectively. IL-1β levels in the femoral 
head cartilage were 23.7, 24.6, and 24.9 pg/mg protein 
in rats in the sham-operated, NGF50, and NGF100 
groups on day 7, and 23.8, 26.3, and 27.3 pg/mg protein 
on day 14, respectively. IL-6 levels in the femoral head 
cartilage were 106.1, 112.3, and 116.8 pg/mg protein in 
rats in the sham-operated, NGF50, and NGF100 groups 
on day 7, and 105.4, 105.6, and 97.7 pg/mg protein on 
day 14, respectively.
Ⅳ．Discussion
 To our knowledge, this is the first report describing 
hip pain-associated changes in gait parameters 
determined by CatWalk, including maximum contact 
area, swing speed, and duty cycle. Intra-articular 
injection of NGF into the hip joint apparently elicits 
pain escape behavior in rats. Miyagi et al. reported 
a rat model of myofascial inflammation using pain-
associated changes of gait parameters assessed using 
the CatWalk system［11］. In the model of myofascial 
inflammation, duty cycle of front and hind paws was 
significantly greater, stride length （the distance between 
successive placements of the same paw） of each paw 
was significantly shorter, and minimum contact intensity 
of the complete paw and mean contact intensity of 
each paw in the myofascial inflammation group were 
significantly greater compared with the control group. 
Yamazaki et al. reported a rat model of unstabilized 
rotator cuff defect using pain-associated changes of 
gait parameters assessed using the CatWalk system
［13］. In the model of unstabilized rotator cuff defect, 
stride length, print area （the area of the paw contact 
with the glass runway surface during locomotion）, and 
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necrosis factor-α, interleukin-1β and cholecystokinin-8: 
the possible role of NGF in the inflammatory response. 
Clin Exp Rheumatol 2003; 21: 617-24.
8 ） Ashraf S, Mapp PI, Burston J, Bennett AJ, Chapman 
V, Walsh DA. Augmented pain behavioural responses 
to intra-articular injection of nerve growth factor in two 
animal models of osteoarthritis. Ann Rheum Dis 2014; 
73: 1710-8.
9 ） Walsh DA, McWilliams DF, Turley MJ, Dixon MR, 
Fransès RE, Mapp PI, et al. Angiogenesis and nerve 
growth factor at the osteochondral junction in rheumatoid 
arthritis and osteoarthritis. Rheumatology （Oxford）. 
2010; 49: 1852-61.
10） Hamers FP, Lankhorst AJ, van Laar TJ, et al. 2001. 
Automated quantitative gait analysis during overground 
locomotion in the rat: its application to spinal cord 
contusion and transaction injuries. J Neurotrauma 18: 
187-201.
11） Miyagi M, Ishikawa T, Kamoda H, Orita S, Kuniyoshi 
K, Ochiai N, et al. Assessment of gait in a rat model of 
myofascial inflammation using the CatWalk system. 
Spine （Phila Pa 1976）. 2011; 36: 1760-4.
12） Miyagi M, Ishikawa T, Kamoda H, Suzuki M, Sakuma 
Y, Orita S, et al. Assessment of pain behavior in a rat 
model of intervertebral disc injury using the CatWalk gait 
analysis system. Spine （Phila Pa 1976）. 2013; 38: 1459-
65.
13） Yamazaki H, Ochiai N, Kenmoku T, Ohtori S, Sasho T, 
Miyagi M, et al. Assessment of pain-related behavior and 
pro-inflammatory cytokine levels in the rat rotator cuff 
tear model. J Orthop Res 2014; 32: 286-90.
14） Sakuma T, Kamoda H, Miyagi M, Ishikawa T, Arai G, 
Eguchi Y, et al. Comparison of CatWalk analysis and von 
Frey testing for pain assessment in a rat model of nerve 
crush plus inflammation. Spine （Phila Pa 1976）. 2013; 
38: E919-24.
15） Takeshita M, Nakamura J, Ohtori S, Inoue G, Orita S, 
Miyagi M, et al. Sensory innervation and inflammatory 
cytokines in hypertrophic synovia associated with pain 
transmission in osteoarthritis of the hip: a case-control 
study. Rheumatology （Oxford）. 2012; 51: 1790-5.
16） Abe H, Sakai T, Ando W, Takao M, Nishii T, Nakamura N, 
et al. Synovial joint fluid cytokine levels in hip disease. 
Rheumatology （Oxford）. 2014; 53: 165-72.
Determination of longer and shorter-term outcomes of 
intra-articular NGF injection is warranted. Third, in the 
CatWalk system, it is not possible to assess whether 
parameters are related to pain or muscle dysfunction 
without pain, and so the possibility that effects are 
related to muscle dysfunction cannot be excluded.
 In conclusion, an increase in synovial levels of 
inflammatory cytokines and pain-related escape behavior 
is observed in a novel rat model of hip pain induced by 
intra-articular administration of NGF into the hip joint.
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